%3Aformat(webp)&w=3840&q=75)
Promore Pharma
Promore Pharma is a biopharmaceutical company that develops peptide-based drug candidates and has two drug candidates in late clinical phase (PXL01 and LL-37). The company's goal is to become a leading company in scarring and wound treatment by developing several drugs to become the first of its kind on the market (first-in-category) for treatment areas with high unmet medical needs and very few pharmaceutical products. The company has been listed on Nasdaq First North Growth Market since 2017 (ticker: PROMO).
Stock price
Company information
No Data Available
%3Aformat(webp)&w=3840&q=75)